If drugmakers are abandoning promising research before a single government-set price has taken effect, the long-term consequences of this policy will be far worse once the controls are fully operational.
Medicare will impose price controls on prescription drugs for the first time when the calendar flips to January. Even before those controls formally take effect, the damage is already being done. The scheme has begun to hollow out America’s biomedical research ecosystem.
Patients will pay the price — in the form of fewer new therapies for disease, particularly cancer.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Terrible Effects of Medicare Price Controls Are Here
Sally C. Pipes
If drugmakers are abandoning promising research before a single government-set price has taken effect, the long-term consequences of this policy will be far worse once the controls are fully operational.
Medicare will impose price controls on prescription drugs for the first time when the calendar flips to January. Even before those controls formally take effect, the damage is already being done. The scheme has begun to hollow out America’s biomedical research ecosystem.
Patients will pay the price — in the form of fewer new therapies for disease, particularly cancer.
Read the op-ed here.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.